What bothers Japanese firms is Donald Trump's unpredictability and the complexity of the tariffs, according to JETRO.

As Washington presses ahead with additional tariffs on products from the European Union (EU) and beyond, European officials and experts are urging the diversification of trade markets to mitigate the ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

Investment management company Vulcan Value Partners recently released its second-quarter 2025 investor letter. A copy of the ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

President Donald Trump says he plans to place tariffs of over 10% on smaller countries, including nations in Africa and the ...

Healthcare delivery organizations are saying they have yet to fully recover financially from the COVID-19 pandemic, and a high level of uncertainty around changing regulations and economic conditions ...

Healthcare costs are already expensive for many. In some states, tariff-related price hikes are showing up in 2026 rate ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...